Page 37 - 81_04

Alzheimer's disease. Chapter 21, 129-152. Kennedy,
D. O, Wightman, E. L, Okello, E. J. Medicinal plants,
phytochemicals and Alzheimer's disease. Chapter 27,
269-290, in Emerging drugs and targets for
Alzheimer’s disease; Volume 2: Neuronal plasticity,
neuronal protection and other miscellaneous
strategies. Ed. A. Martínez. Cambridge: Royal Society
of Chemistry, 2010.
89. Begum AN, Jones MR, Lim GP, Morihara T, Kim P,
Heath DD, Rock CL, Pruitt MA, Yang F, Hudspeth B,
Hu S, Faull KF, Teter B, Cole GM, Frautschy SA.
Curcumin structure-function, bioavailability, and
efficacy in models of neuroinflammation and
Alzheimer's disease. J Pharmacol Exp Ther 2008; 326:
196-208.
90. Wolf LK. Turmeric-derived compound curcumin may
treat Alzheimer's. Chem Eng News 2012; 90: 44-6.
91. Park SY, Kim HS, Cho EK, Kwon BY, Phark S,
Hwang KW, Sul D. Curcumin protected PC12 cells
against beta-amyloid-induced toxicity through the
inhibition of oxidative damage and tau
hyperphosphorylation. Food Chem Toxicol 2008; 46:
2881-7.
92. McCrate OA, Zhou X, Cegelski L. Curcumin as an
amyloid-indicator dye in E. Coli. Chem Commun
2013; 49: 4193-5.
93. Mathew A, Fukuda T, Nagaoka Y, Hasumura T,
Morimoto H, Yoshida Y, Maekawa T, Venugopal K,
Kumar DS. Curcumin loaded-PLGA nanoparticles
conjugated with Tet-1 Peptide for potential use in
Alzheimer's disease. PLoS ONE 2012; 7, e32616: 1-
10.
94. Chojnacki JE, Liu K, Yan X, Toldo S, Selden T,
Estrada M, Rodríguez-Franco MI, Halquist MS, Ye D,
Zhang S. Discovery of 5-(4-hydroxyphenyl)-3-oxo-
pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-
amide as a neuroprotectant for Alzheimer's disease by
hybridization of curcumin and melatonin. ACS Chem
Neurosci 2014; 5: 690-9.
95. Fang L, Gou S, Liu X, Cao F, Cheng L. Design,
synthesis and anti-Alzheimer properties of
dimethylaminomethyl-substituted curcumin
derivatives. Bioorg Med Chem Lett 2014; 24: 40-3.
96. Prior M, Dargusch R, Ehren JL, Chiruta C, Schubert
D. The neurotrophic compound J147 reverses
cognitive impairment in aged Alzheimer's disease
mice. Alzheimer's Res Ther 2013; 5: 25, 1-19.
97. Mayadevi M, Sherin DR, Keerthi VS, Rajasekharan
KN, Omkumar RV. Curcumin is an inhibitor of
calcium/calmodulin dependent protein kinase II.
Bioorg Med Chem 2012; 20: 6040-7.
98. Park K, Seo Y, Kim MK, Kim K, Kim YK, Choo H,
Chong Y. A curcumin-based molecular probe for
near-infrared fluorescence imaging of tau fibrils in
Alzheimer's disease. Org Biomol Chem 2015; 13:
11194-9.
308 @Real Academia Nacional de Farmacia. Spain
J. González-Albadalejo et al.
99. Vajragupta O, Boonchoong P, Morris GM, Olson AJ.
Active site binding modes of curcumin in HIV-1
protease and integrase. Bioorg Med Chem Lett 2005;
15: 3364-8.
100.Mazumder A, Raghavan K, Weinstein J, Kohn KW,
Pommier Y. Inhibition of human immunodeficiency
virus type-1 integrase by curcumin. Biochem
Pharmacol 1995; 49: 1165-70.
101.Mazumder A, Neamati N, Sunder S, Schulz J, Pertz H,
Eich E, Pommier Y. Curcumin analogs with altered
potencies against HIV-1 integrase as probes for
biochemical mechanisms of drug action. J Med Chem
1997; 40: 3057-63.
102.Pommier Y, Johnson AA, Marchand C. Integrase
inhibitors to treat HIV/AIDS. Nature Rev 2005; 4:
236-48.
103.Cohly HHP, Asad S, Das SK, Angel MF, Rao M.
Effect of antioxidant (turmeric, turmerin, curcumin)
on human immunodeficiency virus. Int J Mol Sci
2003; 4: 22-33.
104.Gao X, Kuo J, Jiang H, Deeb D, Liu Y, Divine G,
Chapman RA, Dulchavsky SA, Gautam SC.
Immunomodulatory activity of curcumin: suppression
of lymphocyte proliferation, development of cell-
mediated cytotoxicity, and cytokine production in
vitro. Biochem Pharmacol 2004; 68: 51-61.
105.Kim GY, Kim KH, Lee SH, Yoon MS, Lee HJ, Moon
DO, Lee CM, Ahn SC, Park YC, Park YM. Curcumin
inhibits immunostimulatory function of dendritic
cells: MAPKs and translocation of NF-?B as potential
targets. J Immunol 2005; 174: 8116-24.
106.Jakopin Z. Nucleotide-binding oligomerization
domain (NOD) inhibitors: a rational approach toward
inhibition of NOD signaling pathway. J Med Chem
2014; 57: 6897-918.
107.Singh S, Aggarwal BB. Activation of transcription
factor NF-kappa B is suppressed by curcumin
(diferuloylmethane). J Biol Chem 1995; 270: 24995-
25000.
108.Bhullar KS, Jha A, Youssef D, Rupasinghe HPV.
Curcumin and its carbocyclic analogs: structure-
activity in relation to antioxidant and selected
biological properties. Molecules 2013; 18: 5389-404.
109.Slavova-Kazakova AK, Angelova SE, Veprintsev TL,
Denev P, Fabbri D, Dettori MA, Kratchanova M,
Naumov VV, Trofimov AV, Vasil'ev RF, Delogu G.
Antioxidant potential of curcumin-related compounds
studied by chemiluminescence kinetics, chain-
breaking efficiencies, scavenging activity (ORAC)
and DFT calculations. Beilstein J Org Chem 2015; 11:
1398-411.
110.Jovanovic SV, Steenken S, Boone CW, Simic MG. H-
Atom transfer is a preferred antioxidant mechanism of
curcumin. J Am Chem Soc 1999; 121: 9677-81.
111.Kong L, Priyadarsini KI, Zhang HY. A theoretical
investigation on intramolecular hydrogen-atom